|
Clinical characteristics of the patients in the events investigated. |
||
| Parameter |
Total evaluations (%) |
Evaluations in VAP group (%) |
|
|
||
| Number of evaluations |
219 (100%) |
38 (100%) |
| Tracheostomy (n [%]) |
59 (26.9%) |
10 (26.3%) |
| Atelectasisa (n [%]) |
13 (6.0%) |
6 (15.7%) |
| Lung edemaa (n [%]) |
35 (16.0%) |
9 (23.6%) |
| Lung contusiona (n [%]) |
6 (2.7%) |
1 (2.6%) |
| Pleural effusiona (n [%]) |
21 (9,5%) |
8 (21.0%) |
| Previous lung disease (n [%]) |
30 (13.6%) |
6 (15.7%) |
| COPD |
16 (7.3%) |
3 (7.8%) |
| Cancer |
11 (5.0%) |
2 (5.2%) |
| Asthma |
2 (0.9%) |
1 (2.6%) |
| Pulmonary fibrosis |
1 (0.4%) |
None |
| Broncoaspiration (n [%]) |
12 (5.4%) |
3 (7.8%) |
| Sepsis (n [%]) |
46 (21.0%) |
14 (36.8%) |
| ARDS (n [%]) |
12 (5,4%) |
3 (7.8%) |
| Renal failure (n [%]; creatinine >2.0 mg/dl) |
91 (41.5%) |
20 (52.6%) |
| Diabetes (n [%]) |
35 (16.0%) |
5 (13.1%) |
| Chemotherapy (n [%]) |
13 (6.0%) |
2 (5.2%) |
| Radiotherapy (n [%]) |
2 (0.9%) |
None |
| Immunossupressants drugs (n [%]) |
5 (2.2%) |
1 (2.6%) |
| AIDS (n [%]) |
3 (1.3%) |
None |
| Renal transplantation (n [%]) |
5 (2.2%) |
1 (2.6%) |
| Abdominal surgery (n [%]) |
32 (14.6%) |
7 (18.4%) |
| Multiple trauma (n [%]) |
21 (9.5%) |
3 (7.9%) |
| Neuromuscular blocking agents (n [%]) |
7 (3.1%) |
7 (18.4%) |
| Central venous line (n [%]) |
215 (98.0%) |
38 (100%) |
| Intracranial pressure monitoring (n [%]) |
20 (9.1%) |
1 (2.6%) |
|
aAccording to clinical judgement. ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease; VAP, ventilator-associated pneumonia. | ||
Camargo et al. Critical Care 2004 8:R422 doi:10.1186/cc2965 |
||